Oral microbiome and mycobiome dynamics in cancer therapy-induced oral mucositis (opens in a new tab)
Sci Data
BacteriaMicrobiotaMouth
Dr. Joseph R. Kelley, MD, PhD
NPI1376751354PAC ID0941373609
- Medicare services, 2024
- 7,927
- Medicare patients, 2024
- 255
- Part D claims, 2024
- 356
- Publications
- 1
- Clinical trials
- 5
- Practice address
- 600 Hospital Dr, Clyde, NC 28721
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Adventhealth Hematology Oncology Infusion Services Haywood - HOPD
Acute Care Hospital outpatient department · Clyde, North Carolina
Find Dr. Kelley's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Joseph R. Kelley is a radiation oncologist in Clyde, North Carolina
Dr. Kelley practices at Adventhealth Hematology Oncology Infusion Services Haywood - HOPD in Clyde, North Carolina.
Dr. Kelley's NPI, 1376751354, was assigned on May 21, 2007. Dr. Kelley graduated from Medical University of South Carolina College of Medicine in 2003. Dr. Kelley holds North Carolina license 2021-02149.
NPI and contact details
- NPI
- 1376751354NPI Registry (opens in a new tab)
- Medicare PAC ID
- 0941373609
- NPI enumeration date
- May 21, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 49
- Medical school graduation
- 2003
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Joseph R. Kelley practices at Adventhealth Hematology Oncology Infusion Services Haywood - HOPD in Clyde, North Carolina
Dr. Kelley's primary practice is Adventhealth Hematology Oncology Infusion Services Haywood - HOPD, at 600 Hospital Dr, Clyde, NC 28721.
- Adventhealth Hematology Oncology Infusion Services Haywood - HOPD600 Hospital Dr, Clyde, NC 28721
Source: Dmand AI Affiliation Data
Dr. Joseph R. Kelley is affiliated with 5 sites of care and 4 medical groups
Dr. Kelley's primary practice is Adventhealth Hematology Oncology Infusion Services Haywood - HOPD in Clyde, North Carolina. Dr. Kelley is also affiliated with Haywood Regional Medical Center. The medical group on file is Asheville Urological Associates. Dmand AI also links Dr. Kelley to 2 more hospitals, 3 medical groups and 1 group practice or clinic, each named with a free account. Dr. Kelley's employer is on file too: a hospital.
Adventhealth Hematology Oncology Infusion Services Haywood - HOPDPrimary
Source: Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Joseph R. Kelley's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kelley practices, 5 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Adventhealth Hematology Oncology Infusion Services Haywood - HOPD | Available with a free account |
| +4 more sites and 3 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Kelley practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Joseph R. Kelley is one of 206 radiation oncologists in North Carolina
Radiation oncology is Dr. Kelley's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Kelley is licensed in North Carolina.
Specialties and state licenses
- Radiation oncology, North CarolinaPrimary
Radiation oncologists near Dr. Kelley
Counts of radiation oncologists with a Dmand AI profile, by place and practice. Each opens the list.
206radiation oncologists in North Carolina
2radiation oncologists in Clyde
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Joseph R. Kelley billed Medicare for 7,927 services in 2024
CMS data shows 7,927 Medicare services from Dr. Kelley across 24 procedure codes in 2024, for 255 Medicare patients. Medicare paid $1,266,922 for them. Every service was in an office.
Medicare services, 20247,927
Medicare patients255
Paid by Medicare$1.3M
Procedure codes24
Dr. Kelley's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Imaging
- 2023: 3,1312024: 4,44242%
- Other services
- 2023: 14,2712024: 3,13778%
- Office and hospital visits
- 2023: 2892024: 34820%
Dr. Kelley compared with the North Carolina median for radiation oncologists, 2024
- Dr. Kelley
- North Carolina median
- Medicare services
- 7,927vs 1,2926.1 times
- Medicare patients
- 255vs 18240% above
- Part D claims
- 260vs 426.2 times
Medians across 199 radiation oncologists in North Carolina with Dmand AI profiles that report each measure.
Dr. Kelley's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Kelley?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Kelley and other radiation oncologists in North Carolina.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Joseph R. Kelley treated 255 Medicare patients in 2024, average age 76
CMS counts 255 Medicare patients who saw Dr. Kelley in 2024. The largest group is 65 to 74, with 108 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Kelley's median patient age at 74, with 42% women.
Medicare patients, 2024255
Average age76
Average risk score1.58
Also on Medicaid11%
Dr. Kelley's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Kelley's Medicare patients by sex, 2024
- Women9638%
- Men15962%
Chronic conditions among Dr. Kelley's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Cancer72%
- Arthritis35%
- Ischemic heart disease30%
- Diabetes29%
- Chronic kidney disease25%
- Anxiety23%
Share of Medicare patients with each condition. A patient can have several.
Dr. Kelley's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 74
Patient panel by sex, all payers
- Women42%
- Men57%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Joseph R. Kelley wrote 356 Medicare Part D claims in 2024
In 2024, Dr. Kelley wrote 356 Medicare Part D claims for 126 patients. 89% of them were for generic drugs. CMS names the drug for 260 of them, across 11 drugs with 11 or more claims each, at $3,548 in total drug cost. In 2023, CMS named 173 claims across 8 drugs.
Part D claims, 2024356
Drugs named by CMS11
Total drug cost$3,548
Part D patients126
Dr. Kelley's Part D claims by kind of drug, 2024
- Generic318 claims89%
- Brand-name and other38 claims11%
Dr. Kelley's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Kelley's Part D claims, 2024
- Opioids13%45 of 356 claims
- Antibiotics4%15 of 356 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1732024: 26050%
Drugs named by CMS: 11 in 2024, 8 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Joseph R. Kelley scored 75 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Kelley for performance year 2024, reported individually. Dr. Kelley accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kelley as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- MIPS final score, 2024
- 75 of 100
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Find radiation oncologists like Dr. Kelley by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Joseph R. Kelley has 1 publication on record
Dmand AI links 1 paper to Dr. Kelley in 2025. Dr. Kelley's most frequent co-authors are Laurentia Nodit, MD and Timothy J. Panella, MD.
Papers1
Dr. Kelley's most frequent co-authors
Recent publications by Dr. Kelley
See who Dr. Kelley researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Kelley works with, so you can find a warm path to the right radiation oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Joseph R. Kelley has worked on 5 clinical trials
Dmand AI links Dr. Kelley to 5 clinical trials, 3 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Stomatitis, Carcinoma, Non-Small-Cell Lung and Esophagitis. Galera Therapeutics, Inc. sponsors the most, 3.
Clinical trials with Dr. Kelley by phase
- NonePhase 1: no trials
- 3Phase 2: 3 trials
- 2Phase 3: 2 trials
- NonePhase 4: no trials
Conditions in Dr. Kelley's trials
- Stomatitis
- Carcinoma, Non-Small-Cell Lung
- Esophagitis
- Oral Ulcer
- Salivary Gland Neoplasms
Investigators on the most trials with Dr. Kelley
- William M. Wisbeck, MD3 shared trials
- Carryn M. Anderson, MD2 shared trials
- Douglas F. Ciuba, MD2 shared trials
Recent clinical trials with Dr. Kelley
StomatitisMouth DiseasesCisplatinIntensity-Modulated Radiation TherapyHigh Dose GC4419: 90mg/day
Effects of Intravenous GC4419 on the Incidence and Severity of Esophagitis Due to Chemoradiotherapy for Lung Cancer (opens in a new tab)
TerminatedPhase 2
EsophagitisEsophageal DiseasesGC4419 (avasopasem manganese)
ROMAN: Phase 3 Trial Investigating the Effects of GC4419 on Radiation Induced Oral Mucositis in Head/Neck Cancer Patients (opens in a new tab)
CompletedPhase 3
Oral UlcerStomatitisGC4419 90mg
QUILT 2.023: A Study of N-803 in Combination With Current Standard of Care vs Standard of Care as First-Line Treatment for Patients With Stage 3 or 4 NSCLC. (opens in a new tab)
Active, not recruitingPhase 3
Carcinoma, Non-Small-Cell LungCarcinoma, BronchogenicCarboplatin + Nab-paclitaxel or Paclitaxel + PembrolizumabCisplatin or Carboplatin + Pembrolizumab + PemetrexedN-803 + Carboplatin + Nab-paclitaxel + Ipilimumab + Nivolumab
Radiation Therapy with or Without Chemotherapy in Treating Patients with High-Risk Malignant Salivary Gland Tumors That Have Been Removed by Surgery (opens in a new tab)
Active, not recruitingPhase 2
Salivary Gland NeoplasmsSalivary Gland DiseasesCisplatin3-dimensional conformal radiation therapyIntensity-modulated radiation therapy
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Joseph R. Kelley received $2,881 in industry payments from 2016 to 2025
CMS Open Payments shows 165 general payments to Dr. Kelley from 38 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $484.
General payments to Dr. Kelley by program year, 2016 to 2025
Companies that paid Dr. Kelley the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Joseph R. Kelley graduated from Medical University of South Carolina College of Medicine
Dr. Kelley graduated from Medical University of South Carolina College of Medicine in 2003.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Joseph R. Kelley's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Joseph R. Kelley
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Joseph R. Kelley's NPI number?
Dr. Joseph R. Kelley's NPI number is 1376751354. It was assigned on May 21, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Joseph R. Kelley?
Dr. Joseph R. Kelley is a radiation oncologist in Clyde, North Carolina. The primary specialty in the NPI Registry is Radiation Oncology Physician (taxonomy code 2085R0001X).
Where does Dr. Joseph R. Kelley practice?
Dr. Kelley practices at 600 Hospital Dr, Clyde, NC 28721. Dr. Kelley's primary practice is Adventhealth Hematology Oncology Infusion Services Haywood - HOPD in Clyde, North Carolina. Dmand AI also links Dr. Kelley to 2 hospitals, 3 medical groups and 1 group practice or clinic.
What is Dr. Joseph R. Kelley's medical license number?
Dr. Kelley holds North Carolina license 2021-02149.
Which hospitals is Dr. Joseph R. Kelley affiliated with?
Dr. Kelley is affiliated with Haywood Regional Medical Center. Dmand AI links Dr. Kelley to 2 more hospitals.
What medical group is Dr. Joseph R. Kelley part of?
Dr. Kelley is linked to Asheville Urological Associates. Dmand AI links Dr. Kelley to 3 more medical groups.
Does Dr. Joseph R. Kelley accept Medicare?
Yes. CMS data shows Dr. Kelley billed Medicare for 7,927 services in 2024, and Dr. Kelley accepts Medicare assignment.
Does Dr. Joseph R. Kelley offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Kelley as offering telehealth services.
What is Dr. Joseph R. Kelley's MIPS score?
Dr. Kelley's MIPS final score for performance year 2024 is 75 out of 100, reported individually.
How many Medicare patients does Dr. Joseph R. Kelley see?
CMS counts 255 Medicare patients who saw Dr. Kelley in 2024, with an average age of 76.
Show 7 more questionsShow fewer questions
What services does Dr. Joseph R. Kelley bill to Medicare?
In 2024, Dr. Kelley's most billed Medicare services were medicare service (G6015), radiation oncology (77014) and radiation oncology (77300).
Where did Dr. Joseph R. Kelley go to medical school?
Dr. Kelley graduated from Medical University of South Carolina College of Medicine in 2003.
What drugs does Dr. Joseph R. Kelley prescribe most?
In 2024 Medicare Part D data, Dr. Kelley's most prescribed drugs by claims were Tamsulosin HCl, Pentoxifylline and Mometasone Furoate.
Has Dr. Joseph R. Kelley received payments from drug or device companies?
CMS Open Payments shows $2,881 in general payments to Dr. Kelley from 38 companies from 2016 to 2025. The largest total came from Bristol-Myers Squibb Company.
How long has Dr. Joseph R. Kelley been practicing?
Dr. Kelley graduated from medical school in 2003, 23 years ago.
Does Dr. Joseph R. Kelley do research?
Dmand AI links 1 publication to Dr. Kelley. Dr. Kelley has worked on 5 clinical trials.
Who does Dr. Joseph R. Kelley publish with?
Dr. Kelley's most frequent co-authors are Laurentia Nodit, MD (1 shared paper) and Timothy J. Panella, MD (1 shared paper).
Selling to radiation oncology practices?
See radiation oncologists in North Carolina by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card